WeVote
Log In

Bill

Bill

A 6145

Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.

2024-2025 Regular Session Introduced by Sean Kean

New Jersey bill classifies kratom's primary alkaloid as Schedule I, banning its sale and making possession illegal statewide.

#hazsubstanc
0
WeVote Research Nonpartisan
Bill Summary · A 6145

Legislative bill overview

Bill A 6145 would classify 7-hydroxymitragynine (a primary alkaloid in kratom) as a Schedule I controlled substance in New Jersey and prohibit the sale of any products containing this compound. This represents a significant escalation from current kratom regulation, which is largely uncontrolled federally and in most states, though some jurisdictions have implemented restrictions or bans.

Why is this important

Schedule I classification is the most restrictive drug category, typically reserved for substances deemed to have high abuse potential and no accepted medical use. This reclassification would make kratom products—currently available in smoke shops, online retailers, and some health stores—illegal to sell and possess for consumption in New Jersey, affecting thousands of vendors and consumers. The move also signals potential momentum for similar restrictions in other states, which could reshape the kratom market significantly.

Potential points of contention

  • Kratom's legal status and use: Kratom remains legal federally and is used by many consumers for pain management, opioid withdrawal, and other purposes; classifying only one alkaloid may be scientifically inconsistent since kratom contains multiple alkaloids in varying ratios
  • Medical evidence debate: Limited FDA approval or clinical evidence exists for kratom's safety/efficacy, but also limited evidence of serious harm; classification as Schedule I presupposes no medical value, which advocates dispute
  • Economic and personal freedom concerns: Existing kratom users and vendors argue sudden prohibition creates economic hardship and restricts access to a substance many rely on; enforcement raises questions about possession penalties

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.